Zobrazeno 1 - 3
of 3
pro vyhledávání: '"TNFR1, TNF receptor 1"'
Autor:
Gong, Ke, Guo, Gao, Beckley, Nicole, Zhang, Yue, Yang, Xiaoyao, Sharma, Mishu, Habib, Amyn A.
Publikováno v:
Neoplasia (New York, N.Y.)
Tumor necrosis factor (TNF) and its receptors are widely expressed in non-small cell lung cancer (NSCLC). TNF has an established role in inflammation and also plays a key role in inflammation-induced cancer. TNF can induce cell death in cancer cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e8b516daf685f177d5f7b56fbeccc0e
http://europepmc.org/articles/PMC7773536
http://europepmc.org/articles/PMC7773536
Autor:
Liyuan Cao, Wei Mu
Publikováno v:
Pharmacological Research
Graphical abstract
Necrostatin-1 (Nec-1) is a RIP1-targeted inhibitor of necroptosis, a form of programmed cell death discovered and investigated in recent years. There are already many studies demonstrating the essential role of necroptosis in
Necrostatin-1 (Nec-1) is a RIP1-targeted inhibitor of necroptosis, a form of programmed cell death discovered and investigated in recent years. There are already many studies demonstrating the essential role of necroptosis in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b673f8b687ffb866bd8f37e46b2c624
Autor:
Mustafa, S., Martin, H.L., Burkly, L., Costa, A., Martins, M.L., Schwaninger, M., Teismann, P.
Publikováno v:
Neuroscience
Highlights • We investigate the role of TWEAK and Fn14 in a model of Parkinson’s disease. • Ablation of TWEAK or Fn14 had no effect on acute MPTP toxicity. • TWEAK neutralizing antibody provided neuroprotection in the sub-acute MPTP-model.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::43b6b48a99bee3fa0ef357e7585e1343